
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC-T) has shown resilience and growth, particularly in Asia and wealth management, despite recent challenges such as a new tax on its products in Mainland China. The stock appears to be experiencing a phase of high expectations, as evidenced by its notable ranking among Canadian equities. While some experts express caution due to valuations approaching overbought territory, they also recognize MFC's solid fundamentals, including a healthy dividend yield and strong asset management. However, the stock has prompted mixed sentiments regarding its potential for further gains amidst a dynamic financial landscape, with some analysts suggesting it may be time to accumulate shares during a market pullback. Overall, the stock's performance is closely watched, with a general understanding that lower interest rates and strategic positioning may lead to a continued upward trajectory.
Made $1 billion a quarter for the last 5 quarters. Dividend is about 3.3%. Huge footprint in China. Rising interest rates. Stock price has gone straight down. Why is it not being rewarded for good earnings? You are asking the inexpressible. The value is there. Also, with the latest economic numbers out of Canada suggesting an interest rate hike, that will be very bullish for insurance companies generally. He likes the value in the stock.
Has had a nice move off the 2016 $18 level. Some of that is in tandem with the backup of interest rates. Beyond that though there are the company specific growth opportunities which are pretty good. What he likes most is their Asian division, which is growing by leaps and bounds. Also, their wealth management division is pretty strong. The one drawback is their US operations and they’ve been talking about monetizing that by spinning it off, which could be a potential catalyst for them.
They’ve made a million-dollar profit in the last 5 quarters. Why is it going down? In the shorter term, life insurance businesses are very equity sensitive, and particularly interest rate sensitive. The expectation of rates going up in the future, is one reason you would want to own this. Sometimes there is noise in the results of the lifecos and are complex to interpret. There has been a lot of uncertainty regarding interest rates. A well-run company with a global franchise and significant exposure to Asia, so are well positioned over the long-term. If a long-term investor, this is a good one to hold.
He owns others instead. It comes down to quality of management and an ill-timed acquisition of John Hancock. It continues to underperform and they may now spin it out or sell it. It continues not to be a good performer. They have hedged away a lot of the benefit they will get from rising bond prices.
This has recently moved into a multi-year high. Technically, the trend is up, and the stock is outperforming the TSE Composite. Momentum indicators are also very positive. On a seasonal basis, this has reached a peak around late July. It is not unusual for stock after a nice run to reach a peak some time right around this time of year. You may want to take some money off the table. For a longer-term perspective, you could stick with the stock, with the idea of buying some more during its next period of seasonal strength, the middle to the end of October.
It is struggling to go higher. When interest rates go up it is even better for lifecos than the banks. It is a perfect storm for these when rates go up and markets go up. The financial industry is getting lower margins now, however. They are not making a lot in John Hancock and are looking to sell it. They want to push it in to Asia and make a go of it there. It is into a bad time, but you have to pick the right one. He prefers Great West Life (GWO-T).
His main concern about this is their focus in the Far East, particularly China. He doesn’t trust some of the foreign regimes to stay out of the business. If you are into those areas, you have added a political risk. This company has perked up recently. It’s not a bad company, but the exposure in the Far East has added an element of risk that he is not willing to accept.